Detalhe da pesquisa
1.
Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate.
Protein Expr Purif
; 190: 106003, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34688919
2.
Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain-based vaccine candidate, RBD219-N1C1.
Appl Microbiol Biotechnol
; 105(10): 4153-4165, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33959781
3.
A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2.
Vaccines (Basel)
; 11(10)2023 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37896960
4.
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern.
Vaccine
; 40(26): 3655-3663, 2022 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35568591
5.
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern.
bioRxiv
; 2022 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34268512
6.
SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice.
bioRxiv
; 2021 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33173864
7.
SARSCoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice.
Hum Vaccin Immunother
; 17(8): 2356-2366, 2021 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33847226
8.
Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate.
Biochim Biophys Acta Gen Subj
; 1865(6): 129893, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33731300
9.
Advancing a vaccine to prevent hookworm disease and anemia.
Vaccine
; 34(26): 3001-3005, 2016 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27040400
10.
Status of vaccine research and development of vaccines for leishmaniasis.
Vaccine
; 34(26): 2992-2995, 2016 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26973063
11.
New vaccines for neglected parasitic diseases and dengue.
Transl Res
; 162(3): 144-55, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23578479
12.
Status of vaccine research and development of vaccines for Chagas disease.
Vaccine
; 34(26): 2996-3000, 2016 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27026146